TNFRSF4-eiwit (C-His-AVI, menselijk)

TNFRSF4

ACT35, CD134, IMD16, OX40, TXGP1L

C-His-AVI

< 1.0 EU per μg protein as determined by the LAL method.

≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC. ≥ 95 % as determined by SEC-MALS (Routinely tested) .

1.Immobilized Recombinant Human OX40 Protein (His & AVI Tag), Biotinylated (Cat: 10481-H49H-B) at 2 μg/mL (100 μL/well) on streptavidin precoated (2 μg/mL, 100 μL/well) can bind Recombinant Human OX-40L / TNFSF4 / CD252 Protein (ECD, Fc Tag) (Cat: 13127-H01H), the EC50 is 4-12 ng/mL (QC tested) . 2.Immobilized Anti-OX40 (Research grade Vonlerolizumab biosimilar) at 2 μg/mL (100 μL/well) can bind Recombinant Human OX40 Protein (His & AVI Tag), Biotinylated (Cat: 10481-H49H-B), the EC50 is 0.4-1.5 ng/mL (Routinely tested) . 3.Immobilized Recombinant Human OX40 Protein (His & AVI Tag), Biotinylated (Cat: 10481-H49H-B) at 1 μg/mL (100 μl/well) on streptavidin precoated (5 μg/mL, 100 μL/well) can bind Anti-OX40 (Research grade Vonlerolizumab biosimilar), the EC50 is 1.6 ng/mL (Routinely tested) .

Met1-Ala216

The recombinant human TNFRSF4 consists of 213 amino acids and predicts a molecular mass of 23.34 kDa. It migrates as an approximately 38.6 kDa band in SDS-PAGE under reducing conditions. The molecular weight of this protein is around 38.0 kDa verified by SEC-MALS (Routinely tested) .

Human